BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
235.94
+3.69 (1.59%)
May 8, 2025, 4:00 PM - Market closed
BeiGene Employees
BeiGene had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$379,624
Profits / Employee
-$35,670
Market Cap
25.47B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ONC News
- 23 hours ago - BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit - Seeking Alpha
- 1 day ago - BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat - Benzinga
- 2 days ago - BeiGene Announces First Quarter 2025 Financial Results and Business Updates - Business Wire
- 9 days ago - U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene - Business Wire
- 22 days ago - BeiGene to Announce First Quarter 2025 Financial Results on May 7 - Business Wire
- 5 weeks ago - BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit - Benzinga
- 5 weeks ago - BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program - Business Wire